TradingFloor AI · Stock Terminal

SYK - Ticker AI Digest

Stryker Corporation
US500
281.62000000 | Today -0.33% ●
Desk Snapshot GO VIP Login
Important AI Risk Notice

Charts, catalyst summaries, AI scores, forecasts and price context are AI-driven and can hallucinate, lag or miss market-changing information.

Not investment advice. Markets can move fast and any trade or allocation decision remains your responsibility.
AI can hallucinate. Summaries, rankings, forecasts and commentary can be wrong, incomplete or misleading.
AI-driven data only. Signals, dates, prices, sentiment and automation outputs may be delayed, estimated or stale.
Always verify externally. Confirm prices, filings, broker notes and trade setup details with independent sources before acting.
Mobile Command Deck
Stryker Corporation in one cleaner mobile flow.
Tap straight into the module you want. No sideways tab hunt, just a clean route into charts, news, Today’s AI, and the deeper desks.
SYK Data 2026-10-15 Preview Mode
Core Deck
Deep Dive Modules
Home

Digested News

Today's Catalysts (SYK) 0
No same-day market news for SYK on 2026-10-15.
AI 0
No items for this category on selected date.
Acquisition 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Admission 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
AssetDisposal 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
BlockListing 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
BondPricing 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CapitalReduction 0
No items for this category on selected date.
CashGenerationGrowth 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Circular 0
No items for this category on selected date.
ClinicalTrial 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
CommercialControl 0
No items for this category on selected date.
CommercialDeployment 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
DebtEquityConversion 0
No items for this category on selected date.
DeferredShareAwards 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
DirectorateChange 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Dividend 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
FarmDown 0
No items for this category on selected date.
Form83 0
No items for this category on selected date.
FrameworkAppointment 0
No items for this category on selected date.
GeneralMeeting 0
No items for this category on selected date.
GovernmentCommentary 0
No items for this category on selected date.
GovernmentInvestment 0
No items for this category on selected date.
GrantApplication 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
GrowthFacility 0
No items for this category on selected date.
GuidanceUpgrade 0
No items for this category on selected date.
IndexAdmission 0
No items for this category on selected date.
InfrastructureMilestone 0
No items for this category on selected date.
InstitutionalInvestment 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
InvestorWebinar 0
No items for this category on selected date.
IssueOfEquity 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
LeadershipAppointment 0
No items for this category on selected date.
LicenseAcquisition 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
MineralDiscovery 0
No items for this category on selected date.
MonthlyFactsheet 0
No items for this category on selected date.
NAV 0
No items for this category on selected date.
NameChange 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
OwnShares 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
PaymentAmendment 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
ProductionMilestone 0
No items for this category on selected date.
ProfitWarning 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Prospectus 0
No items for this category on selected date.
RegulatoryAccreditation 0
No items for this category on selected date.
RegulatoryApproval 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 0
No items for this category on selected date.
RetailExpansion 0
No items for this category on selected date.
SalesMilestone 0
No items for this category on selected date.
SchemeOfArrangement 0
No items for this category on selected date.
SharePurchasePlan 0
No items for this category on selected date.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
StrategicInvestment 0
No items for this category on selected date.
StrategicPartner 0
No items for this category on selected date.
StrategicPartnership 0
No items for this category on selected date.
SubscriptionCompletion 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
TVR 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
TakeoverPosition 0
No items for this category on selected date.
TechnologyValidation 0
No items for this category on selected date.
TrafficStatistics 0
No items for this category on selected date.
US News 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 2
SYK 19:21
Stryker Corporation
Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS
SYK 17:20
Stryker Corporation
Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
Stryker’s CFO disclosed at a September 8, 2026 conference that a peripheral vascular manufacturing issue, previously thought resolved, persists, causing a $26.70 (‑8.8%) share decline and erasing over $10 billion of market value. The announcement triggered an Hagens Berman investigation into potential securities‑law violations. Prior close was $284.76, and the company’s market cap of $124.49 bn is stale, limiting valuation context. The event is materially negative, with strong negative catalyst and credible disclosure, but novelty is low as the issue recurs. Missing fresh EV data and sector benchmarks temper confidence.

Stryker’s CFO disclosed at a September 8, 2026 conference that a peripheral vascular manufacturing issue, previously thought resolved, persists, causing a $26.70 (‑8.8%) share decline and erasing over $10 billion of market value. The announcement triggered an Hagens Berman investigation into potential securities‑law violations. Prior close was $284.76, and the company’s market cap of $124.49 bn is stale, limiting valuation context. The event is materially negative, with strong negative catalyst and credible disclosure, but novelty is low as the issue recurs. Missing fresh EV data and sector benchmarks temper confidence.

Today's AI

SYK · Agentic Market Intelligence

SYK intelligence is listening.

The engine is monitoring news, price structure, forecasts and financial changes. New scored evidence will appear here against this stock automatically.

Live catalyst scoringAI price pathsRisk-aware triggersFinancial blend
AI bias0.0
Bullish0
Bearish0
Today's AI Starts With News

Today’s AI opens with the latest catalyst tape for SYK.

No same-day headline has printed on 2026-10-15 yet, but the latest digestion still leads Today’s AI before the findings and blend stack below. Financial Forecastist remains wired into the blend.
Standby Tape Data 2026-10-15 Blend Lower Down
Read the alert tape first, then open Today’s AI findings. Use AI Expand on any card to open the AI explanation, results tables and financial forecast rows instantly.
0 Today
Front Of Desk
The live alert stack is quiet right now, but the latest digestion is still parked at the top before the findings and blend stack below.
19:21 Latest Tape Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS
Single-Ticker Today's AI
SYK signal theatre built from scored market catalysts, automated AI forecasts, financial forecasting and live trigger logic.

This is the ticker-specific Today’s AI desk for Stryker Corporation. It compresses the live catalyst tape, bullish and bearish scoring, AI price forecasts, financial forecasting and trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI + Financial Blend Buy / Sell Trigger Engine Today's AI Findings
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full SYK Today’s AI cockpit.

Subscription turns this tab into a live signal desk with today’s news findings at the top, AI plus financial blend comparisons at the bottom, buy and sell trigger logic, and the full findings ledger behind every scored row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific Today’s AI stack, sentiment gauges, AI blend stage, and the full findings ledger for SYK on 2026-10-15.

Fundamentals Matrix

About Stryker Corporation
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

🌐 Visit Official Website ↗

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
SYK Target Setup
Signal: Pending
Market Profile
Signal: Pending
Ticker
SYK
Market Cap
124.5B
Enterprise Value
136.9B
Public Float
90.7
Broker Target
386.8
Shares Out
383.4M
Long Interest
0
Short Interest
0
Exchange
NYSE
Currency Code
USD
ISIN
US8636671013
Ex-Dividend
2026-06-30
Yield
1.08%
Dividend Rate
3.52
EPS
8.65
Index
S&P 500
Market
NYSE
Standard Lists
US500
Sector
Software and Computer ServicesUS fundamentals
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

News And Alerts First

The alert tape opens the door for SYK, and Financial Forecastist sits just below.

No same-day alert has printed on 2026-10-15 yet, but the latest digestion is pinned here first so the forecastist view below still opens with context instead of raw numbers.
Standby Alerts Data 2026-10-15 Forecastist Below
Read the alert tape first, then move into Financial Forecastist below. Use AI Expand on any catalyst card to open the AI explanation and results tables without losing the ticker context.
0 Alerts
Front Of Desk
The live alert stack is quiet right now, but the latest digestion is still parked at the top before the forecastist read below.
19:21 Latest Alert Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS
Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
3.52
Ex Divi
2026-06-30
Earnings Date
-
Net Debt
12.3B
Cash
4.0B
EPS
8.65
Net Income
3.2B
Revenue
25.3B
Enterprise Value
136.9B
Trailing PE
37.541
Forward PE
21.7865
Price Sales TTM
4.9263
Price Book MRQ
5.4477
EV Revenue
5.4191
EV EBITDA
21.2674
Financial Forecastist

Improving financial engine

Revenue is accelerating +2.6% against the prior comparable period. Net margin is expanding by 1.2 pts. Net debt is coming down +17.8%.

Revenue +2.6% Net Income +13.9% FCF +226.8% Current Ratio 2.11x Forward Rev 6.7B
Improving
Quarter Revenue
6.0B
+2.6%
vs prior comparable quarter
Net Margin
+12.4%
+1.2 pts
profitability pulse
Free Cash Flow
415.0M
+226.8%
cash conversion
Net Debt / EBITDA
9.5x
-17.8%
lower is cleaner
Revenue Engine

Latest quarter printed 6.0B with the top line pushing higher against the last comparable period.

Profit Stack

Net income landed at 745.0M and the margin profile is broadening. That usually tells us whether operating leverage is finally kicking in.

Balance-Sheet Pressure

Cash sits near 2.9B while net debt is 12.4B. The leverage stack is cleaning up.

Quarterly Revenue Runway

Actual revenue bars, consensus revenue where available, plus the terminal model path.

Profit And Cash Conversion

Net income and free cash flow moving together is usually what separates genuine improvement from noise.

Balance-Sheet Pressure

Cash, net debt and liquidity tell us whether the business is strengthening or just surviving.

Annual Power Curve

Longer-cycle revenue and net income help frame whether the company is compounding or rolling over.
Q3 2025
Consensus
6.0B
Revenue Path
3.13
EPS / Earnings
Growth cue +0.1%
Q1 2026
Consensus
6.3B
Revenue Path
2.98
EPS / Earnings
Growth cue +0.1%
Q2 2026
Consensus
6.6B
Revenue Path
3.49
EPS / Earnings
Growth cue +0.1%
Q3 2026
Consensus
6.7B
Revenue Path
3.68
EPS / Earnings
Growth cue +0.2%
FY 2026
Consensus
27.3B
Revenue Path
14.98
EPS / Earnings
Growth cue +0.1%
FY 2027
Consensus
29.6B
Revenue Path
16.72
EPS / Earnings
Growth cue +0.1%

Quarterly Statement Tape

Last 6 Quarters
Period Revenue Net Income FCF Net Debt
Q1 2026 6.0B 745.0M 415.0M 12.4B
Q4 2025 7.2B 849.0M 1.9B 12.3B
Q3 2025 6.1B 859.0M 1.4B 14.3B
Q2 2025 6.0B 884.0M 928.0M 14.8B
Q1 2025 5.9B 654.0M 127.0M 15.0B
Q4 2024 6.4B 546.0M 1.7B 10.5B

Annual Financial Power

Last 5 Years
Period Revenue Net Income EBITDA FCF
FY 2025 25.1B 3.2B 6.3B 4.3B
FY 2024 22.6B 3.0B 4.9B 3.5B
FY 2023 20.5B 3.2B 5.1B 3.1B
FY 2022 18.4B 2.4B 4.0B 2.0B
FY 2021 17.1B 2.0B 3.6B 2.7B

Structure DNA

Market Structure DNA

Income Anchor profile with trend mixed

Price is 36.9% through the 52-week range, +5.1% vs 50DMA and -6.6% vs 200DMA. 87.7% of the register is locked by institutions and insiders, leaving 12.3% free float. Capital rhythm reads quarterly with forward yield near 1.1% and payout around 26.0%.

Trend mixed Institutional gravity Reliable income rhythm As Of 2026-07-07
Income Anchor
Structure Score
70.4 / 100
Income Anchor
Trend Stack
+5.1% / -6.6%
vs 50DMA / 200DMA
52W Position
36.9%
auction position inside the yearly range
Ownership Lock
87.7%
82.3% institutions | 5.4% insiders
Pressure Pocket
1.7% short float
Short ratio 2.2x | monthly +6.8%
Capital Rhythm
Quarterly
Yield 1.1% | payout 26.0%
Trend Runway

Implied spot is 324.73 with the stock +5.1% vs 50DMA and -6.6% vs 200DMA. The tape is sitting 36.9% through the 52-week range, which frames the regime as trend mixed.

Ownership Register

Institutions hold about 82.3% and insiders about 5.4%, locking roughly 87.7% of the register and leaving 12.3% in free float. That reads as institutional gravity.

Pressure Pocket

Short pressure is running near 1.7% of float with short ratio 2.2x and monthly change +6.8%. That gives us a read on whether the tape is clean, crowded, or coiled.

Capital Rhythm

Dividend cadence reads quarterly with 4 event(s) in the last full year, a five-year average of 4.0, and stability score 100.0/100. Forward yield sits near 1.1% while payout is around 26.0%.

Structure Score

One-glance gauge for the current market-structure regime.

Pillar Radar

Trend, ownership, pressure, and capital rhythm mapped on one wheel.

Position And Float Balance

Shows whether the stock is extended, tightly held, or carrying capital-return support.

Dividend Cadence Tape

Historical dividend-event counts help reveal how dependable the income rhythm has been.

Dividend Cadence Ledger

Quarterly
Year Dividend Count Context
2026 2 Current partial year
2025 4 Full year
2024 4 Full year
2023 4 Full year
2022 4 Full year
2021 4 Full year
2020 4 Full year
2019 4 Full year

Structure Facts

Live Snapshot
Implied Spot
324.73
derived from market cap / shares
52W High
400.79
upper auction edge
52W Low
280.25
lower auction edge
Beta
0.78
volatility character
Shares Out
383.4M
fully diluted count
Shares Float
347.6M
tradable register
Shares Short
6.1M
borrowed stock
Short Ratio
2.2x
days-to-cover style read
Ex-Dividend
2026-06-30
-7 day(s) to ex-date
Dividend Pay
2026-07-31
24 day(s) to pay date
Last Split
2:1
2004-05-17

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
70.661
Institutions As Of
2026-05-31
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
0
Sale Director Dealing
0
Purchase TR1
0
Sale TR1
0
Broker Coverage Rows
0
Institution Holders Tracked
40
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data · SYK · Last 30 Days

Short D · 12/26 EMA spread with 9 signal

Red histogram bars show short loading accelerating. Green bars show short covering accelerating. The two lines expose the crossover before the raw holder table does.

Short D waiting

Building SYK short-momentum read

Short D compares the ticker’s disclosed short-position momentum with its own signal line.

Short D—
Signal—
Momentum—

Declared Short Holders

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

News And Alerts First

Start with the latest alert tape for SYK, then drop into AI Charts below.

No same-day headline has printed on 2026-10-15 yet, but the latest digestion is parked at the top before the chart workspace below so users can frame price, AI targets and structure from the latest tape.
Standby Tape Data 2026-10-15 AI Charts Below
Read the alert tape first, then move into AI Charts below. Use AI Expand on any catalyst card to open the AI explanation and results tables instantly.
0 Today
Catalyst Pulse
The live alert stack is quiet right now, but the latest digestion is still parked at the top before the chart read below.
19:21 Latest Tape Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS
AI Charts Studio
SYK Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2026-10-15 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
Desk Snapshot Member Login
AI AutoDetection Automatic bull / bear chart read
Detected market structure
Analysing selected range
Why this call
Waiting for sufficient price history.
Invalidation
—
Updates with the timeframe.
Bull caseCalculating upside confirmation.
Bear caseCalculating downside confirmation.
Indicators0
Technicals0
RSI Gauge
Price Change
AI Forecast